This three-day CME meeting is designed to offer expert perspectives and practical insights into the use of immunotherapy and targeted treatments in cancer care. It will feature a multidisciplinary faculty that will explore the role of these innovative therapies for the treatment of melanoma, genitourinary cancer, lung cancer, head and neck cancer and hematologic malignancies, including leukemia, multiple myeloma and
Discussions will include how immunotherapy and targeted therapies fit into the treatment paradigm; best practices to ensure optimal treatment timing, sequencing and duration; methods to predict and assess response; and strategies to manage toxicity. You will leave the meeting with the confidence to use these modalities to provide optimal care while ensuring patient safety.
The program content is pertinent to the entire cancer care
team, including hematologists/oncologists from academic or community practices, nurses, physician assistants, researchers
Participate in one of the best educational experiences in oncology:
- Join face-to-face discussions with renowned specialists who
will explain how you can apply the new research and advances presented to your own patients and practice.
- Engage faculty and peers during interactive periods including case study discussions, head-to-head debates and audience response sessions.
- Earn educational credits and keep your practice current with up to 21 AMA PRA Category 1 Credit(s)™.
- Network and mingle during the “Meet the Faculty” reception and exhibit hall breaks scheduled throughout the program.
We look forward to seeing you in New York City for this exciting educational opportunity.
Drs. Agarwala, Kim and Porter